560 related articles for article (PubMed ID: 29946821)
21. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
[TBL] [Abstract][Full Text] [Related]
22. Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms.
Čokić VP; Mitrović-Ajtić O; Beleslin-Čokić BB; Marković D; Buač M; Diklić M; Kraguljac-Kurtović N; Damjanović S; Milenković P; Gotić M; Raj PK
Mediators Inflamm; 2015; 2015():453020. PubMed ID: 26491227
[TBL] [Abstract][Full Text] [Related]
23. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
24. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.
Laouedj M; Tardif MR; Gil L; Raquil MA; Lachhab A; Pelletier M; Tessier PA; Barabé F
Blood; 2017 Apr; 129(14):1980-1990. PubMed ID: 28137827
[TBL] [Abstract][Full Text] [Related]
25. The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis.
Cerezo LA; Remáková M; Tomčik M; Gay S; Neidhart M; Lukanidin E; Pavelka K; Grigorian M; Vencovský J; Šenolt L
Rheumatology (Oxford); 2014 Aug; 53(8):1520-6. PubMed ID: 24643522
[TBL] [Abstract][Full Text] [Related]
26. S100A8 is a novel therapeutic target for anaplastic thyroid carcinoma.
Reeb AN; Li W; Sewell W; Marlow LA; Tun HW; Smallridge RC; Copland JA; Spradling K; Chernock R; Lin RY
J Clin Endocrinol Metab; 2015 Feb; 100(2):E232-42. PubMed ID: 25423568
[TBL] [Abstract][Full Text] [Related]
27. Differential release and deposition of S100A8/A9 proteins in inflamed upper airway tissue.
Van Crombruggen K; Vogl T; Pérez-Novo C; Holtappels G; Bachert C
Eur Respir J; 2016 Jan; 47(1):264-74. PubMed ID: 26493794
[TBL] [Abstract][Full Text] [Related]
28. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4.
Schelbergen RF; Blom AB; van den Bosch MH; Slöetjes A; Abdollahi-Roodsaz S; Schreurs BW; Mort JS; Vogl T; Roth J; van den Berg WB; van Lent PL
Arthritis Rheum; 2012 May; 64(5):1477-87. PubMed ID: 22127564
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms.
Liang F; Liang X; Pan L; Jin Q; Deng J; Hong M; Wei W; Hao Z; Ren H; Wang H; Chen X
Clin Exp Med; 2024 May; 24(1):106. PubMed ID: 38771542
[TBL] [Abstract][Full Text] [Related]
30. S100A9 gene silencing inhibits the release of pro-inflammatory cytokines by blocking the IL-17 signalling pathway in mice with acute pancreatitis.
Wu DM; Wang S; Shen M; Wang YJ; Zhang B; Wu ZQ; Lu J; Zheng YL
J Cell Mol Med; 2018 Apr; 22(4):2378-2389. PubMed ID: 29441717
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic Kras expression in postmitotic neurons leads to S100A8-S100A9 protein overexpression and gliosis.
Ryu MJ; Liu Y; Zhong X; Du J; Peterson N; Kong G; Li H; Wang J; Salamat S; Chang Q; Zhang J
J Biol Chem; 2012 Jun; 287(27):22948-58. PubMed ID: 22577135
[TBL] [Abstract][Full Text] [Related]
32. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis.
Chen YS; Yan W; Geczy CL; Brown MA; Thomas R
Arthritis Res Ther; 2009; 11(2):R39. PubMed ID: 19284577
[TBL] [Abstract][Full Text] [Related]
34. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
[TBL] [Abstract][Full Text] [Related]
35. S100A8/A9: From basic science to clinical application.
Pruenster M; Vogl T; Roth J; Sperandio M
Pharmacol Ther; 2016 Nov; 167():120-131. PubMed ID: 27492899
[TBL] [Abstract][Full Text] [Related]
36. S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-κB pathways.
Kang JH; Hwang SM; Chung IY
Immunology; 2015 Jan; 144(1):79-90. PubMed ID: 24975020
[TBL] [Abstract][Full Text] [Related]
37. Characterization of CD34+ hematopoietic progenitor cells in JAK2V617F and CALR-mutated myeloproliferative neoplasms.
Angona A; Alvarez-Larrán A; Bellosillo B; Longarón R; Camacho L; Fernández-Rodríguez MC; Pairet S; Besses C
Leuk Res; 2016 Sep; 48():11-5. PubMed ID: 27427771
[TBL] [Abstract][Full Text] [Related]
38. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.
Ehlermann P; Eggers K; Bierhaus A; Most P; Weichenhan D; Greten J; Nawroth PP; Katus HA; Remppis A
Cardiovasc Diabetol; 2006 Mar; 5():6. PubMed ID: 16573830
[TBL] [Abstract][Full Text] [Related]
39. S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.
Oesterle A; Bowman MA
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2496-507. PubMed ID: 26515415
[TBL] [Abstract][Full Text] [Related]
40. Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera.
Lussana F; Carobbio A; Salmoiraghi S; Guglielmelli P; Vannucchi AM; Bottazzi B; Leone R; Mantovani A; Barbui T; Rambaldi A
J Hematol Oncol; 2017 Feb; 10(1):54. PubMed ID: 28228104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
